BIOCON

& Civica Team Join Forces to Make Insulin More Affordable in the U.S.💊

Subsidiary Biologics partners with Civica to enhance access to Insulin Aspart in the U.S. Under this strategic collaboration, Biocon will supply the drug substance, while Civica will manufacture and distribute the final product. This initiative aims to combat rising diabetes rates and ensure affordable insulin for millions of Americans.